1478-3231/asset/LIV_left.gif?v=1&s=85fae709761c931e1b1f055c02ebb481958f0f73)
Basic Studies
You have free access to this content
Involvement of the apelin receptor APJ in Fas-induced liver injury
Article first published online: 1 NOV 2012
DOI: 10.1111/liv.12006
© 2012 John Wiley & Sons A/S
Additional Information
How to Cite
Yasuzaki, H., Yoshida, S.-i., Hashimoto, T., Shibata, W., Inamori, M., Toya, Y., Tamura, K., Maeda, S. and Umemura, S. (2013), Involvement of the apelin receptor APJ in Fas-induced liver injury. Liver International, 33: 118–126. doi: 10.1111/liv.12006
Publication History
- Issue published online: 10 DEC 2012
- Article first published online: 1 NOV 2012
- Accepted manuscript online: 5 OCT 2012 08:23AM EST
- Manuscript Accepted: 5 SEP 2012
- Manuscript Received: 29 FEB 2012
References
- 1, , , et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136: 355–60.
- 2, , , et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471–6.
- 3, . Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005; 107: 198–211.
- 4, , , et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000; 275: 21061–7.
- 5, , , et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538: 162–71.
- 6, , , et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005; 65: 73–82.
- 7, , , et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 2007; 171: 1705–12.
- 8, , , et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008; 118: 3343–54.
- 9, , , et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999; 1452: 25–35.
- 10, , , et al. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol 1998; 72: 6113–8.
- 11, , , . Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007; 26: 7692–9.
- 12, , , et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004; 325: 395–400.
- 13, , , et al. The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 2008; 48: 1193–201.
- 14, , , et al. Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut 2011; 60: 1404–11.
- 15, , , . Fas and Fas ligand in gut and liver. Am J Physiol Gastrointest Liver Physiol 2000; 278: G354–66.
- 16, , , et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223–30.
- 17, , , et al. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 2001; 276: 26605–13.
- 18, , , et al. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. J Hepatol 2001; 34: 723–9.
- 19, , , et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137–45.
- 20, , , et al. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. J Biol Chem 2001; 276: 32585–90.
- 21. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 2002; 109: 437–41.
- 22, , , . Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: role of CYP2E1 and TNF-alpha and activation of JNK and P38 MAP kinase. Free Radic Biol Med 2009; 47: 518–28.
- 23, , , et al. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 2003; 38: 899–914.
- 24, , , et al. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 2006; 116: 2493–9.
- 25, , , et al. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways. Peptides 2007; 28: 708–18.
- 26, , , et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004; 279: 26274–9.
- 27, , , et al. High hepatic glutathione stores alleviate Fas-induced apoptosis in mice. J Hepatol 2007; 46: 858–68.
- 28, , , et al. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF. J Hepatol 2006; 44: 1046–54.
- 29, , . Isolation and culture of adult mouse hepatocytes. Methods Mol Biol 2010; 633: 185–96.
- 30, . Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and -independent pathways. Free Radic Biol Med 2007; 42: 971–84.
- 31, , , et al. The neuronal isoform of constitutive nitric oxide synthase is up-regulated in the macula densa of angiotensinogen gene-knockout mice. Lab Invest 1997; 76: 285–94.
- 32, , , et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003; 112: 989–98.
- 33. Fas ligand-induced apoptosis. Annu Rev Genet 1999; 33: 29–55.
- 34, , , . Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver. Hepatol Res 2012; 42: 508–14.
- 35, , , et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006; 124: 601–13.
- 36
- 37, , , et al. Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes. Faseb J 2004; 18: 720–2.
- 38, , , et al. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated MAPK. Hepatology 2011; 54: 185–95.